Skip to main content
. 2020 Aug 17;26:e927106-1–e927106-13. doi: 10.12659/MSM.927106

Figure 1.

Figure 1

Omipalisib was identified as a potential agent against Esophageal squamous cell carcinoma (ESCC). (A) MTT assay was used to screen compounds in a 1404-compound library. (B) In total, 13 compounds showed inhibitory effects on 4 ESCC cell lines. (C) Chemical structure of omipalisib.